targapremir-210

N/A

Report date: 2023/05/17 08:52:04
NME

Base Information

Drug Nametargapremir-210
Drug Alias Nametargapremir-210TGP-210
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial permeability transition pore inhibitors
TargetsMitochondrial permeability transition pore
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Scripps Research Institute Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A